Trisomy 21 enhances human fetal erythro-megakaryocytic development

Stella T Chou1, Joanna B Opalinska, Yu Yao

  • 1Division of Hematology, The Children's Hospital of Philadelphia, PA, USA

Blood
|September 25, 2008
PubMed

Insights

Down syndrome (trisomy 21) in fetal blood cells promotes excessive growth of red blood and platelet precursors. This may increase the risk of developing leukemia later in life.

Area of Science:

  • Hematology
  • Genetics
  • Developmental Biology

Background:

  • Children with Down syndrome (DS) have increased risks for transient myeloproliferative disorder (TMD) and acute megakaryoblastic leukemia (AMKL).
  • Both conditions involve abnormal blood cell precursors (blasts) with GATA1 mutations, but the role of trisomy 21 itself in fetal hematopoiesis is unclear.
  • DS is characterized by an extra copy of chromosome 21, impacting gene expression and cellular development.

Purpose of the Study:

  • To investigate how trisomy 21 affects fetal blood formation independently of GATA1 mutations.
  • To understand the cellular basis for the increased risk of TMD and AMKL in individuals with Down syndrome.

Main Methods:

  • Studied hematopoiesis in trisomy 21 fetal liver cells using in vitro assays.
  • Employed mouse transplantation models to assess the function of trisomy 21 hematopoietic progenitors.
  • Analyzed cell proliferation and differentiation patterns.

Main Results:

  • Trisomy 21 fetal liver progenitors showed enhanced production of erythroid and megakaryocytic cells.
  • These progenitors exhibited excessive proliferation in a cell-autonomous manner.
  • Normal GATA1 alleles were present, indicating trisomy 21's direct impact.

Conclusions:

  • Trisomy 21 directly promotes the overgrowth of red blood and platelet precursor cells in the fetal liver.
  • This expansion of susceptible progenitor cells may create a pre-leukemic state, increasing the risk for TMD and AMKL development.
  • Understanding these early events is crucial for preventing hematologic malignancies in Down syndrome.

Related Concept Videos

Karyotyping01:17

Karyotyping

Describing the number and physical features of chromosomes can reveal abnormalities that underlie genetic diseases. This description is facilitated by special staining techniques that produce a particular banding pattern on each chromosome. State-of-the-art techniques make this approach even more powerful, enabling the detection of individual genes that cause disease.A Simple Chromosome Staining Technique Provides Valuable Scientific InsightSome genetic diseases can be detected by looking at...
Meiosis I01:49

Meiosis I

Meiosis is a carefully orchestrated set of cell divisions, the goal of which—in humans—is to produce haploid sperm or eggs, each containing half the number of chromosomes present in somatic cells elsewhere in the body. Meiosis I is the first such division, and involves several key steps, among them: condensation of replicated chromosomes in diploid cells; the pairing of homologous chromosomes and their exchange of information; and finally, the separation of homologous chromosomes by a...
Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
Nondisjunction01:21

Nondisjunction

Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...
Nondisjunction01:29

Nondisjunction

During meiosis, chromosomes occasionally separate improperly. This occurs due to failure of homologous chromosome separation during meiosis I or failed sister chromatid separation during meiosis II. In some species, notably plants, nondisjunction can result in an organism with an entire additional set of chromosomes, which is called polyploidy. In humans, nondisjunction can occur during male or female gametogenesis and the resulting gametes possess one too many or one too few chromosomes.
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...